|
[1]
|
Guerra, J.V.S., Dias, M.M.G., Brilhante, A.J.V.C., Terra, M.F., García-Arévalo, M. and Figueira, A.C.M. (2021) Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases. Nutrients, 13, Article 2830. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., et al. (2022) Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. International Journal of Molecular Sciences, 23, Article 786. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Xie, Y., Huang, Y., Ling, X., Qin, H., Wang, M. and Luo, B. (2020) Chemerin/CMKLR1 Axis Promotes Inflammation and Pyroptosis by Activating NLRP3 Inflammasome in Diabetic Cardiomyopathy Rat. Frontiers in Physiology, 11, Article ID: 381. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Zhang, X., Weiß, T., Cheng, M.H., Chen, S., Ambrosius, C.K., Czerniak, A.S., et al. (2023) Structural Basis of G Protein-Coupled Receptor CMKLR1 Activation and Signaling Induced by a Chemerin-Derived Agonist. PLOS Biology, 21, e3002188. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Lin, Y., Xiao, L., Cai, Q., Zhu, C., Li, S., Li, B., et al. (2021) The Chemerin-CMKLR1 Axis Limits Thermogenesis by Controlling a Beige Adipocyte/IL-33/Type 2 Innate Immunity Circuit. Science Immunology, 6, eabg9698. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Zhao, Z., Liu, S., Qian, B., Zhou, L., Shi, J., Liu, J., et al. (2024) CMKLR1 Senses Chemerin/Resolvin E1 to Control Adipose Thermogenesis and Modulate Metabolic Homeostasis. Fundamental Research, 4, 575-588. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Zhao, L., Zhou, J., Abbasi, F., Fathzadeh, M., Knowles, J.W., Leung, L.L.K., et al. (2024) Chemerin in Participants with or without Insulin Resistance and Diabetes. Biomedicines, 12, Article 924. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Xie, Y. and Liu, L. (2022) Role of Chemerin/CHemR23 Axis as an Emerging Therapeutic Perspective on Obesity-Related Vascular Dysfunction. Journal of Translational Medicine, 20, Article No. 141. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Su, X., Cheng, Y., Zhang, G. and Wang, B. (2021) Chemerin in Inflammatory Diseases. Clinica Chimica Acta, 517, 41-47. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Salaga, M., Bartoszek, A., Binienda, A., Krajewska, J.B., Fabisiak, A., Mosińska, P., et al. (2021) Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice. Nutrients, 13, Article 2716. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Wang, G., Muñoz-Rojas, A.R., Spallanzani, R.G., Franklin, R.A., Benoist, C. and Mathis, D. (2024) Adipose-Tissue Treg Cells Restrain Differentiation of Stromal Adipocyte Precursors to Promote Insulin Sensitivity and Metabolic Homeostasis. Immunity, 57, 1345-1359.e5. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Hammad, M.M., Channanath, A.M., Abu-Farha, M., Rahman, A., Al Khairi, I., Cherian, P., et al. (2023) Adolescent Obesity and ANGPTL8: Correlations with High Sensitivity C-Reactive Protein, Leptin, and Chemerin. Frontiers in Endocrinology, 14, Article ID: 1314211. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
R, A., P, R., VM, V. and SN, M.S. (2024) Circulating Chemerin Levels in Obese and Non-Obese Individuals and Its Association with Obesity in Metabolic Dysfunction-Associated Fatty Liver Disease. Cureus, 16, e68105. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Schmid, A., Roderfeld, M., Karrasch, T., Roeb, E. and Schäffler, A. (2023) Serum Chemerin Is Decreased by Roux-En-Y Gastric Bypass and Low Calorie-Formula Diet in Obese Individuals. Biomedicines, 12, Article 33. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Supriya, R., Shishvan, S.R., Kefayati, M., Abednatanzi, H., Razi, O., Bagheri, R., et al. (2023) Astaxanthin Supplementation Augments the Benefits of Crossfit Workouts on Semaphorin 3C and Other Adipokines in Males with Obesity. Nutrients, 15, Article 4803. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Haberl, E.M., Pohl, R., Rein-Fischboeck, L., Feder, S., Eisinger, K., Krautbauer, S., et al. (2018) Ex Vivo Analysis of Serum Chemerin Activity in Murine Models of Obesity. Cytokine, 104, 42-45. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Tu, J., Yang, Y., Zhang, J., Lu, G., Ke, L., Tong, Z., et al. (2020) Regulatory Effect of Chemerin and Therapeutic Efficacy of Chemerin-9 in Pancreatogenic Diabetes Mellitus. Molecular Medicine Reports, 21, 981-988. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Sáinz, N., Fernández-Galilea, M., Costa, A.G.V., Prieto-Hontoria, P.L., Barraco, G.M. and Moreno-Aliaga, M.J. (2020) N-3 Polyunsaturated Fatty Acids Regulate Chemerin in Cultured Adipocytes: Role of GPR120 and Derived Lipid Mediators. Food & Function, 11, 9057-9066. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Zhang, R., Liu, S., Guo, B., Chang, L. and Li, Y. (2014) Chemerin Induces Insulin Resistance in Rat Cardiomyocytes in Part through the ERK1/2 Signaling Pathway. Pharmacology, 94, 259-264. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Wang, D., Wang, H., Li, M. and Zhao, R. (2022) Chemerin Levels and Its Genetic Variants Are Associated with Gestational Diabetes Mellitus: A Hospital-Based Study in a Chinese Cohort. Gene, 807, Article 145888. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Jun, L., Lin-Lin, S. and Hui, S. (2021) Chemerin Promotes Microangiopathy in Diabetic Retinopathy via Activation of ChemR23 in Rat Primary Microvascular Endothelial Cells. Molecular Vision, 27, 575-587.
|
|
[22]
|
Wang, L., Zhang, Y., Guo, Y., Ding, W., Chang, A., Wei, J., et al. (2021) Chemerin/CMKLR1 Axis Promotes the Progression of Proliferative Diabetic Retinopathy. International Journal of Endocrinology, 2021, Article ID: 4468625. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Elmahdy, A.G., Ibrahim, M.M., Salama, O.H., Ziada, H., Ali, M.M., Elmohaseb, G.F., et al. (2022) Association of the Serum Chemerin Level with the Development of Diabetic Retinopathy in Patients with Type 1 Diabetes Mellitus. Medical hypothesis discovery and innovation in ophthalmology, 11, 171-178. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Yasir, M., Senthilkumar, G.P., Jayashree, K., Ramesh Babu, K., Vadivelan, M. and Palanivel, C. (2022) Association of Serum Omentin-1, Apelin and Chemerin Concentrations with the Presence and Severity of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients. Archives of Physiology and Biochemistry, 128, 313-320. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Pohl, R., Haberl, E.M., Rein‐Fischboeck, L., Zimny, S., Neumann, M., Aslanidis, C., et al. (2017) Hepatic Chemerin mRNA Expression Is Reduced in Human Nonalcoholic Steatohepatitis. European Journal of Clinical Investigation, 47, 7-18. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Huang, C., Wang, M., Ren, L., Xiang, L., Chen, J., Li, M., et al. (2016) CMKLR1 Deficiency Influences Glucose Tolerance and Thermogenesis in Mice on High Fat Diet. Biochemical and Biophysical Research Communications, 473, 435-441. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
An, X., Liu, J., Li, Y., Dou, Z., Li, N., Suo, Y., et al. (2021) Chemerin/CMKLR1 Ameliorates Nonalcoholic Steatohepatitis by Promoting Autophagy and Alleviating Oxidative Stress through the JAK2-STAT3 Pathway. Peptides, 135, Article 170422. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Toth, P.P., Fazio, S., Wong, N.D., Hull, M. and Nichols, G.A. (2020) Risk of Cardiovascular Events in Patients with Hypertriglyceridaemia: A Review of Real‐World Evidence. Diabetes, Obesity and Metabolism, 22, 279-289. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Chinetti-Gbaguidi, G., Colin, S. and Staels, B. (2015) Macrophage Subsets in Atherosclerosis. Nature Reviews Cardiology, 12, 10-17. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Yanofsky, R., Sancho, C., Gasbarrino, K., Zheng, H., Doonan, R.J., Jaunet, F., et al. (2021) Expression of Resistin, Chemerin, and Chemerin’s Receptor in the Unstable Carotid Atherosclerotic Plaque. Stroke, 52, 2537-2546. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Liu, H., Xiong, W., Luo, Y., Chen, H., He, Y., Cao, Y., et al. (2019) Adipokine Chemerin Stimulates Progression of Atherosclerosis in ApoE−/− Mice. BioMed Research International, 2019, Article ID: 7157865. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Goralski, K.B., Jackson, A.E., McKeown, B.T. and Sinal, C.J. (2019) More than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer. International Journal of Molecular Sciences, 20, Article 4778. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
He, Y., Wang, R., Zhang, P., Yan, J., Gong, N., Li, Y., et al. (2021) Curcumin Inhibits the Proliferation and Migration of Vascular Smooth Muscle Cells by Targeting the Chemerin/CMKLR1/LCN2 Axis. Aging, 13, 13859-13875. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Stener-Victorin, E. and Deng, Q. (2021) Epigenetic Inheritance of Polycystic Ovary Syndrome—Challenges and Opportunities for Treatment. Nature Reviews Endocrinology, 17, 521-533. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Lansdown, A. and Rees, D.A. (2012) The Sympathetic Nervous System in Polycystic Ovary Syndrome: A Novel Therapeutic Target? Clinical Endocrinology, 77, 791-801. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Singh, A., Choubey, M., Bora, P. and Krishna, A. (2018) Adiponectin and Chemerin: Contrary Adipokines in Regulating Reproduction and Metabolic Disorders. Reproductive Sciences, 25, 1462-1473. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Mansoori, A., Amoochi‐Foroushani, G., Zilaee, M., Hosseini, S.A. and Azhdari, M. (2022) Serum and Follicular Fluid Chemerin and Chemerin mRNA Expression in Women with Polycystic Ovary Syndrome: Systematic Review and Meta‐Analysis. Endocrinology, Diabetes & Metabolism, 5, e00307. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Estienne, A., Mellouk, N., Bongrani, A., Plotton, I., Langer, I., Ramé, C., et al. (2021) Involvement of Chemerin and CMKLR1 in the Progesterone Decrease by PCOS Granulosa Cells. Reproduction, 162, 427-436. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Lin, K., Sun, X., Wang, X., Wang, H. and Chen, X. (2021) Circulating Adipokine Levels in Nonobese Women with Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology, 11, Article ID: 537809. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Mehrabani, S., Arab, A., Karimi, E., Nouri, M. and Mansourian, M. (2021) Blood Circulating Levels of Adipokines in Polycystic Ovary Syndrome Patients: A Systematic Review and Meta-Analysis. Reproductive Sciences, 28, 3032-3050. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Wang, X., Zhang, Q., Zhang, L., Wei, W., Liu, L., Li, B., et al. (2022) Circulating Chemerin Levels in Women with Polycystic Ovary Syndrome: A Meta-Analysis. Gynecological Endocrinology, 38, 22-27. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Yen, H., Chang, Y., Yee, F. and Huang, Y. (2021) Metformin Therapy for Acne in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. American Journal of Clinical Dermatology, 22, 11-23. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Lima, P.D.A., Nivet, A., Wang, Q., Chen, Y., Leader, A., Cheung, A., et al. (2018) Polycystic Ovary Syndrome: Possible Involvement of Androgen-Induced, Chemerin-Mediated Ovarian Recruitment of Monocytes/Macrophages. Biology of Reproduction, 99, 838-852. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Zhai, Y. and Pang, Y. (2022) Systemic and Ovarian Inflammation in Women with Polycystic Ovary Syndrome. Journal of Reproductive Immunology, 151, Article 103628. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Kennedy, A.J. and Davenport, A.P. (2018) International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function. Pharmacological Reviews, 70, 174-196. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Neves, K.B., Nguyen Dinh Cat, A., Alves-Lopes, R., Harvey, K.Y., Costa, R.M.D., Lobato, N.S., et al. (2018) Chemerin Receptor Blockade Improves Vascular Function in Diabetic Obese Mice via Redox-Sensitive and Akt-Dependent Pathways. American Journal of Physiology-Heart and Circulatory Physiology, 315, H1851-H1860. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Peng, Z., Wang, X., Zhu, Q., Wang, H., Li, B., Pang, X., et al. (2023) CMKLR1 Antagonist Alpha-Neta Protects against Diabetic Nephropathy in Mice. Kidney and Blood Pressure Research, 48, 405-413. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Yun, H., Dumbell, R., Hanna, K., Bowen, J., McLean, S.L., Kantamneni, S., et al. (2022) The Chemerin-CMKLR1 Axis Is Functionally Important for Central Regulation of Energy Homeostasis. Frontiers in Physiology, 13, Article ID: 897105. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Graham, K.L., Zhang, J.V., Lewén, S., Burke, T.M., Dang, T., Zoudilova, M., et al. (2014) A Novel CMKLR1 Small Molecule Antagonist Suppresses CNS Autoimmune Inflammatory Disease. PLOS ONE, 9, e112925. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Ji, Z., Jiang, H., Xie, Y., Wei, Q., Yin, X., Ye, J., et al. (2022) Chemerin Promotes the Pathogenesis of Preeclampsia by Activating CMKLR1/p-Akt/CEBPɑ Axis and Inducing M1 Macrophage Polarization. Cell Biology and Toxicology, 38, 611-628. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Tümmler, C., Snapkov, I., Wickström, M., Moens, U., Ljungblad, L., Maria Elfman, L.H., et al. (2017) Inhibition of Chemerin/CMKLR1 Axis in Neuroblastoma Cells Reduces Clonogenicity and Cell Viability in Vitro and Impairs Tumor Growth in Vivo. Oncotarget, 8, 95135-95151. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Wang, D., Mahmud, I., Thakur, V.S., Tan, S.K., Isom, D.G., Lombard, D.B., et al. (2024) GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma. Cancer Research, 84, 2141-2154. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Kumar, V., LaJevic, M., Pandrala, M., Jacobo, S.A., Malhotra, S.V. and Zabel, B.A. (2019) Novel CMKLR1 Inhibitors for Application in Demyelinating Disease. Scientific Reports, 9, Article No. 7178. [Google Scholar] [CrossRef] [PubMed]
|